Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses

American Journal of Clinical Pathology

Volumn 107, Issue 4, 1997, Pages 451-458

  Ghazizadeh, Mohammad ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Grade; Ovarian carcinoma; Prognosis; Proliferating cell nuclear antigen; Silver stained nucleolar organizer regions; Stage; Subtype

Indexed keywords

CELL NUCLEUS ANTIGEN;

ARTICLE; CANCER STAGING; CELL PROLIFERATION; CHROMOSOME NOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; OVARY TUMOR; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SILVER STAINING;

EID: 0030909955     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.4.451     Document Type: Article

References (9)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7-26.
2. Omura GA, Brady MF, Homesley HD. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol. 1991;9:1138-1150.
3. Aure JC, Hoeg K, Kolstad P. Clinical and histological studies of ovarian carcinoma: long-term follow-up of 900 cases. Obstet Gynecol. 1971;37:1-9.
4. Richardson GS, Scully RE, Nikrui N, Nelson JH Jr. Common epithelial cancer of the ovary. N Engl J Med. 1985;312:415-424.
5. Averette H, Donato D. Ovarian carcinoma: advances in diagnosis, staging, and treatment. Cancer. 1990;65:703-708.
6. Friedlander ML, Dembo AJ. Prognostic factors in ovarian cancer. Semin Oncol. 1991;18:205-212.
7. Young RC, Walton LA, Ellenberg SS, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials. N Engl J Med. 1990;322: 1021-1027.
8. Wong WSF, Tattersall MHN. Immunohistochemical determination of tumor growth fraction in human ovarian carcinoma. Br J Obstet Gynaecol. 1989;96:720-724.
9. Isola J, Kallioniemi O-P, Korte J-M, et al. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol. 1990;162:295-301.